Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Designing HDAC-PROTACs: lessons learned so far.
Fischer F, Alves Avelar LA, Murray L, Kurz T. Fischer F, et al. Among authors: alves avelar la. Future Med Chem. 2022 Jan;14(3):143-166. doi: 10.4155/fmc-2021-0206. Epub 2021 Dec 24. Future Med Chem. 2022. PMID: 34951318 Free article. Review.
Recent advances in class IIa histone deacetylases research.
Asfaha Y, Schrenk C, Alves Avelar LA, Hamacher A, Pflieger M, Kassack MU, Kurz T. Asfaha Y, et al. Among authors: alves avelar la. Bioorg Med Chem. 2019 Nov 15;27(22):115087. doi: 10.1016/j.bmc.2019.115087. Epub 2019 Sep 6. Bioorg Med Chem. 2019. PMID: 31561937 Review.
Establishment and Evaluation of Dual HDAC/BET Inhibitors as Therapeutic Options for Germ Cell Tumors and Other Urological Malignancies.
Burmeister A, Stephan A, Alves Avelar LA, Müller MR, Seiwert A, Höfmann S, Fischer F, Torres-Gomez H, Hoffmann MJ, Niegisch G, Bremmer F, Petzsch P, Köhrer K, Albers P, Kurz T, Skowron MA, Nettersheim D. Burmeister A, et al. Among authors: alves avelar la. Mol Cancer Ther. 2022 Nov 3;21(11):1674-1688. doi: 10.1158/1535-7163.MCT-22-0207. Mol Cancer Ther. 2022. PMID: 35999659 Free PMC article.
14 results